Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (561-570 of 1,016) with videos related to

Pageof 102
Sort By:
The Journal of Community and Supportive Oncology|June 28, 2014
Understanding the experience of living with non-small-cell lung cancer (NSCLC): a qualitative studyJoanne Buzaglo, Christopher Gayer, Rajiv Mallick, et al.
Psychological Test and Assessment Modeling|September 18, 2018
Measuring social function in diverse cancer populations: Evaluation of measurement equivalence of the Patient Reported Outcomes Measurement Information SystemElizabeth A Hahn, Michael A Kallen, Roxanne E Jensen, et al.
Cancer|May 19, 2012
Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI)Zeeshan Butt, Neehar D Parikh, Jennifer L Beaumont, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2014
US valuation of health outcomes measured using the PROMIS-29Benjamin M Craig, Bryce B Reeve, Paul M Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group studyBradley J Monk, Michael W Sill, D Scott McMeekin, et al.
Journal of Pain and Symptom Management|September 27, 2005
An item response theory-based pain item bank can enhance measurement precisionJin-Shei Lai, Kelly Dineen, Bryce B Reeve, et al.
Gynecologic Oncology|September 15, 2010
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group studyDavid Cella, Helen Q Huang, Bradley J Monk, et al.
Pediatric Dermatology|December 17, 2016
Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for TreatmentJamie L Mull, Sarah L Chamlin, Jin-Shei Lai, et al.
The British Journal of Dermatology|July 30, 2024
Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL) instrumentCaroline Raymundo, David Cella, Lynne I Wagner, et al.
Gynecologic Oncology|March 16, 2007
Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group studyVictoria Champion, Stephen D Williams, Anna Miller, et al.
Pageof 102

Showing results (561-570 of 1,016) with videos related to

Sort By:
Pageof 102
The Journal of Community and Supportive Oncology|June 28, 2014
Understanding the experience of living with non-small-cell lung cancer (NSCLC): a qualitative studyJoanne Buzaglo, Christopher Gayer, Rajiv Mallick, et al.
Psychological Test and Assessment Modeling|September 18, 2018
Measuring social function in diverse cancer populations: Evaluation of measurement equivalence of the Patient Reported Outcomes Measurement Information SystemElizabeth A Hahn, Michael A Kallen, Roxanne E Jensen, et al.
Cancer|May 19, 2012
Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI)Zeeshan Butt, Neehar D Parikh, Jennifer L Beaumont, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2014
US valuation of health outcomes measured using the PROMIS-29Benjamin M Craig, Bryce B Reeve, Paul M Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group studyBradley J Monk, Michael W Sill, D Scott McMeekin, et al.
Journal of Pain and Symptom Management|September 27, 2005
An item response theory-based pain item bank can enhance measurement precisionJin-Shei Lai, Kelly Dineen, Bryce B Reeve, et al.
Gynecologic Oncology|September 15, 2010
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group studyDavid Cella, Helen Q Huang, Bradley J Monk, et al.
Pediatric Dermatology|December 17, 2016
Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for TreatmentJamie L Mull, Sarah L Chamlin, Jin-Shei Lai, et al.
The British Journal of Dermatology|July 30, 2024
Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL) instrumentCaroline Raymundo, David Cella, Lynne I Wagner, et al.
Gynecologic Oncology|March 16, 2007
Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group studyVictoria Champion, Stephen D Williams, Anna Miller, et al.
Pageof 102